Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’

Luca Cantini; Federica Pecci; Floris Dammeijer; Joachim G.J.V. Aerts; Rossana Berardi

doi:10.1016/j.ejca.2021.05.016

Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’

Luca Cantini, Federica Pecci, Floris Dammeijer, Joachim G.J.V. Aerts, Rossana Berardi^*

^*Corresponding author for this work

Pulmonary Medicine

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	267-269
Number of pages	3
Journal	European Journal of Cancer
Volume	153
Early online date	18 Jun 2021
DOIs	https://doi.org/10.1016/j.ejca.2021.05.016
Publication status	Published - Aug 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2021.05.016

Cite this

Cantini, L., Pecci, F., Dammeijer, F., Aerts, J. G. J. V., & Berardi, R. (2021). Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’. European Journal of Cancer, 153, 267-269. https://doi.org/10.1016/j.ejca.2021.05.016

@article{1a769cf8340a4cf08d66a4a35ab102ab,

title = "Re: Comments on {\textquoteleft}High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients{\textquoteright}",

author = "Luca Cantini and Federica Pecci and Floris Dammeijer and Aerts, {Joachim G.J.V.} and Rossana Berardi",

year = "2021",

month = aug,

doi = "10.1016/j.ejca.2021.05.016",

language = "English",

volume = "153",

pages = "267--269",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Cantini, L, Pecci, F, Dammeijer, F , Aerts, JGJV & Berardi, R 2021, 'Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’', European Journal of Cancer, vol. 153, pp. 267-269. https://doi.org/10.1016/j.ejca.2021.05.016

Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’. / Cantini, Luca; Pecci, Federica; Dammeijer, Floris et al.
In: European Journal of Cancer, Vol. 153, 08.2021, p. 267-269.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Re

T2 - Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’

AU - Cantini, Luca

AU - Pecci, Federica

AU - Dammeijer, Floris

AU - Aerts, Joachim G.J.V.

AU - Berardi, Rossana

PY - 2021/8

Y1 - 2021/8

UR - http://www.scopus.com/inward/record.url?scp=85110603213&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2021.05.016

DO - 10.1016/j.ejca.2021.05.016

M3 - Comment/Letter to the editor

C2 - 34154882

AN - SCOPUS:85110603213

SN - 0959-8049

VL - 153

SP - 267

EP - 269

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Cantini L, Pecci F, Dammeijer F , Aerts JGJV, Berardi R. Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’. European Journal of Cancer. 2021 Aug;153:267-269. Epub 2021 Jun 18. doi: 10.1016/j.ejca.2021.05.016

Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’

UN SDGs

Access to Document

Other files and links

Cite this